What are the recommended diagnostic and treatment strategies for diabetes in pediatric patients?

Diabetes in Pediatric Patients: Diagnostic and Treatment Strategies

Type 1 Diabetes (Most Common in Youth)

For children with type 1 diabetes, initiate a basal-bolus insulin regimen using either multiple daily injections or insulin pump therapy, combined with continuous glucose monitoring, targeting an A1C ≤7% (or ≤6.5% with advanced diabetes technology) without severe hypoglycemia. 1, 2

Diagnosis and Initial Management

Type 1 diabetes accounts for 94.2% of pediatric diabetes cases and requires immediate insulin therapy at diagnosis. 3 The diagnostic approach must differentiate between type 1 and type 2 diabetes, which can be challenging given the obesity epidemic:

• Genetic testing is mandatory for all infants diagnosed before 6 months of age to identify neonatal diabetes 4
• Children with atypical presentations (obesity, acanthosis nigricans) may still have type 1 diabetes with positive autoantibodies 1
• DKA occurs in approximately 6% of youth aged 10-19 with type 2 diabetes, further complicating differentiation 1

Insulin Therapy

The cornerstone of treatment is lifelong insulin replacement with individualized dosing:

• Insulin requirements: 0.5-1.0 units/kg/day initially, increasing to 1.5 units/kg/day during puberty due to growth hormone and sex hormone effects 5
• Preferred regimen: Basal-bolus using long-acting insulin analog (glargine) plus rapid-acting analog before meals 5, 2
• Insulin pump therapy or multiple daily injections should be considered for all patients, especially after the honeymoon period 5
• Rapid-acting insulin can be administered after meals in very young children with unpredictable eating patterns 5

Glucose Monitoring

Real-time continuous glucose monitoring (CGM) or intermittently scanned CGM should be offered to all youth with type 1 diabetes on multiple daily injections or pump therapy. 1 This technology improves glycemic control and reduces diabetes burden, particularly when combined with automated insulin delivery (AID) systems. 3

Glycemic Targets

• A1C goal: ≤7% (53 mmol/mol) for most children and adolescents 1, 2
• A1C goal: ≤6.5% (48 mmol/mol) for those using advanced diabetes technologies like AID systems 3
• Time in range (TIR): >70% for all pediatric age groups 3
• Goals must account for hypoglycemia unawareness in children under 6-7 years of age 6

Nutrition and Physical Activity

• Carbohydrate counting or experience-based estimation is essential for insulin dosing 2
• Emphasize nonstarchy vegetables, whole fruits, legumes, fish, lean protein, whole grains, and low-fat dairy 2
• 60 minutes of moderate-to-vigorous physical activity daily, with muscle-strengthening activities at least 3 days/week 2

Complication Screening

Annual screening protocols are critical:

• Retinopathy: Dilated fundoscopy starting at diagnosis or soon after, then annually 1
• Nephropathy: Urine albumin-to-creatinine ratio at diagnosis, then annually starting at age 10 with 5 years diabetes duration 1, 2
• Neuropathy: Foot examination annually including monofilament testing 1
• Blood pressure: At every visit; target <130/80 mmHg in adolescents ≥13 years 1
• Lipid screening: Initially after glycemia optimization, then annually 1
• Thyroid screening: TSH at diagnosis, then every 1-2 years if thyroid peroxidase antibodies positive 2
• Celiac screening: IgA tTG within 2 years of diagnosis, repeat at 5 years 2

---

Type 2 Diabetes (Increasing Incidence)

For youth with type 2 diabetes, initiate metformin immediately at diagnosis alongside intensive lifestyle intervention if A1C <8.5% and asymptomatic; if A1C ≥8.5% or symptomatic, start basal insulin plus metformin concurrently. 1, 7

Diagnosis

Type 2 diabetes is increasing dramatically in adolescents, especially in racial/ethnic minorities. 1 Diagnostic considerations:

• A1C is the preferred diagnostic test in pediatric populations despite some ethnic variations 1
• Screening should begin at age 10 or puberty onset in high-risk youth (BMI ≥85th percentile plus additional risk factors) 8
• Distinguish from type 1 diabetes: Check autoantibodies; presence suggests faster progression to insulin dependence 1

Treatment Algorithm

The treatment approach is stratified by presentation severity:

Metabolically Stable (A1C <8.5%, asymptomatic):

• Metformin monotherapy as first-line pharmacologic treatment if renal function normal 1, 7
• Start at low dose, titrate gradually to minimize gastrointestinal side effects 8
• If A1C target not met after 3-6 months, add basal insulin 1, 9

Marked Hyperglycemia (glucose ≥250 mg/dL, A1C ≥8.5%, symptomatic):

• Initiate basal insulin immediately while starting and titrating metformin 1, 9, 7
• Once glucose targets achieved, insulin can be tapered over 2-6 weeks by decreasing dose 10-30% every few days 9, 7

Ketosis/Ketoacidosis:

• Subcutaneous or intravenous insulin to correct hyperglycemia and metabolic derangement 9, 7
• Once acidosis resolved, initiate metformin while continuing insulin 9, 7
• Consider assessment for hyperglycemic hyperosmolar nonketotic syndrome if glucose ≥600 mg/dL 9, 7

Treatment Intensification:

• If metformin monotherapy fails, add liraglutide (GLP-1 receptor agonist) in children ≥10 years without personal/family history of medullary thyroid carcinoma or MEN2 7
• If basal insulin up to 1.5 units/kg/day inadequate, transition to multiple daily injections with basal and bolus insulin 9, 7

Glycemic Targets

• A1C goal: <7% (53 mmol/mol) for most children on oral agents alone 1, 9
• More stringent target <6.5% (48 mmol/mol) appropriate for selected patients achieving this without significant hypoglycemia 1
• Less stringent target (7.5%) may be appropriate with increased risk of hypoglycemia or treatment burden 1

Lifestyle Intervention

Comprehensive lifestyle programs are mandatory and should be integrated with diabetes management:

• Target 7-10% decrease in excess weight through family-centered approach 1, 9
• Focus on nutrient-dense, high-quality foods; minimize calorie-dense, nutrient-poor foods and sugar-added beverages 1, 7
• 30-60 minutes of moderate-to-vigorous physical activity at least 5 days/week, plus strength training 3 days/week 9, 7
• Decrease sedentary behavior (television, computer use) 8
• Lifestyle intervention must follow chronic care model, not short-term program 1, 9

Metabolic Surgery

Metabolic surgery may be considered for adolescents with BMI >35 kg/m² and uncontrolled glycemia/serious comorbidities despite lifestyle and pharmacologic intervention. 1 This requires an experienced multidisciplinary team including surgeon, endocrinologist, dietitian, behavioral health specialist, and nurse.

Comorbidity Management

Youth with type 2 diabetes have high rates of comorbidities requiring aggressive management:

• Hypertension: ACE inhibitor or ARB for elevated albumin-to-creatinine ratio (30-299 mg/g) or strongly recommended if >300 mg/g 1
• Dyslipidemia: Target LDL <100 mg/dL, HDL >35 mg/dL, triglycerides <150 mg/dL 1
• Screen and treat aggressively as cardiovascular disease risk is accelerated in youth-onset type 2 diabetes 1

Critical Pitfalls

• Do not use medications not FDA-approved for pediatric type 2 diabetes outside research trials 9, 7
• Metformin is contraindicated with impaired renal function and must be discontinued with radiocontrast material 8
• ACE inhibitors/ARBs are teratogenic; provide reproductive counseling to females of childbearing age 1
• Youth-onset type 2 diabetes is more aggressive than adult-onset with rapid β-cell decline and accelerated complications 10

---

Essential Care Components for All Pediatric Diabetes

Multidisciplinary Team Approach

Care must be provided by an interprofessional team trained in pediatric diabetes including endocrinologist, diabetes educator, dietitian, behavioral health specialist, and nurse. 1, 2 This is non-negotiable for optimal outcomes.

Diabetes Self-Management Education and Support (DSMES)

• Comprehensive, culturally sensitive, developmentally appropriate DSMES must be provided at diagnosis and routinely thereafter 1, 2
• Education must address family dynamics, developmental stages, and physiologic differences related to sexual maturity 2
• School/daycare personnel must be informed about diagnosis, hypoglycemia signs/symptoms, and treatment 6

Sick Day Management

Establish sick-day rules at diagnosis including assessment for ketosis with every illness to prevent severe hyperglycemia and DKA. 6 This is particularly critical in young children with more frequent intercurrent illnesses.

Psychosocial Support

Adherence is the major determinant of treatment success. 6 Healthcare providers must evaluate behavioral, emotional, and psychosocial factors interfering with implementation and work with families to resolve problems or modify goals appropriately. Family involvement remains essential throughout childhood and adolescence.